IQGAP1 Mediates VE-Cadherin-Based Cell-Cell Contacts and VEGF Signaling at Adherence Junctions Linked to Angiogenesis
V ascular endothelial growth factor (VEGF) induces angiogenesis by stimulating endothelial cell (EC) migration and proliferation primarily through the VEGF type2 receptor (VEGFR2, KDR/Flk-1). 1 VEGF binding initiates autophosphorylation of VEGFR2, which is followed by activation of diverse key angiogenic enzymes such as MAP kinases and Akt. 1 One of the initial responses of quiescent ECs to induce angiogenesis is the loosening of cell-cell contacts, which is followed by migration of ECs to form capillary tube networks that become functional capillaries. 2 The molecule primarily responsible for cell-cell adhesions of ECs is the transmembrane homophilic adhesion molecule, vascular endothelial (VE)-cadherin. 3 The cytoplasmic domain of VE-cadherin binds to ␤-catenin, which in turn is linked to the actin cytoskeleton via ␣-catenin. 3 This linkage between VE-cadherin-based adherens junctional complex and the actin cytoskeleton contributes to the strong adhesion. Furthermore, deletion or cytosolic truncation of VE-cadherin impairs remodeling and maturation of the vascular networks, and it inhibits VEGF-stimulated Akt phosphorylation induced by formation of a VEGFR2/VE-cadherin/␤-catenin/phosphatidylinositol 3-kinase (PI3 kinase) complex. 4 Tyrosine phosphorylation of the VE-cadherin complex is another mechanism that regulates the stability of cell-cell junctions, [5] [6] [7] which is in part mediated through reactive oxygen species (ROS). 8, 9 We demonstrated that ROS derived from Rac1-dependent NAD(P)H oxidase play an important role in VEGF signaling and angiogenesis in ECs and in vivo. 10, 11 Thus, the VE-cadherin-based endothelial adherens junction is a potential site for initial activation of VEGFR2-mediated, ROSdependent signaling linked to angiogenesis. However, underlying regulatory mechanisms are incompletely understood.
Using a yeast 2-hybrid system, we recently identified IQGAP1 as a novel VEGFR2 binding protein. 12 IQGAP1 is a scaffold protein that interacts directly with actin, E-cadherin, ␤-catenin, active Rac1/Cdc42, calmodulin, and the microtubule plus end binding protein, CLIP-170, [13] [14] [15] thereby regulating actin cytoskeleton, cell-cell adhesion, cellular motility and morphogenesis. IQGAP1 is a downstream effector of active Rac1 16, 17 and acts as anti-GAP through a GAP-related domain, thereby increasing GTP-bound Rac1. 16, 18 In mouse fibroblasts, IQGAP1 localizes at sites of cell-cell contact and overexpression of IQGAP1 reduces E-cadherin-mediated cell-cell adhesion via interacting with ␤-catenin, thereby releasing ␣-catenin from the cadherin/catenin complex. 19 Knockdown of IQGAP1 using siRNA reduces the accumulation of actin filaments, E-cadherin and ␤-catenin at sites of cell-cell contact in MDCKII cells. 20 These results suggest negative and positive roles of IQGAP1 for cell-cell adhesions in epithelial cells. We previously demonstrated that IQGAP1 plays an essential role in VEGF-stimulated ROS production and VEGFR2-mediated EC migration and proliferation. 12 However, a specific role of IQGAP1 in VEcadherin-mediated cell-cell adhesions as well as VEGFinduced loss of cell-cell contacts linked to angiogenesis is unknown.
The present study demonstrates that IQGAP1 colocalizes and forms a complex with VE-cadherin at the site of cell-cell contacts in unstimulated confluent human umbilical vascular endothelial cells (HUVECs). VEGF stimulation reduces the staining of VE-cadherin and IQGAP1 at cell margins without affecting their complex formation. Using IQGAP1 siRNA, we found that IQGAP1 is required for establishment of VE-cadherin-based cell-cell contacts in quiescent ECs. We also suggest that IQGAP1 may function as a scaffold protein to link VEGFR2 to the VE-cadherin/␤-catenin complex at the adherens junctions, thereby promoting VEGF-stimulated ROS-dependent tyrosine phosphorylation of VE-cadherin and its downstream Akt phosphorylation, which may contribute to angiogenesis.
Materials and Methods

Materials
Antibodies to VEGFR2, IQGAP1, phosphotyrosine, VE-cadherin, ␣-catenin, ␤-catenin, Akt, and ␣-tubulin were from Santa Cruz. Anti-phospho-Akt antibody was from Cell Signaling. Human recombinant VEGF 165 was from R&D Systems and BRB Preclinical Repository. Oligofectamine was from Invitrogen Corp. Carboxy-H2-2Ј,7Ј-dichlorofluorescein diacetate (DCF-DA) was from Molecular Probes. All other chemicals and reagents were from Sigma.
Cell culture, measurement of intracellular H 2 O 2 levels, confocal immunofluorescence microscopy, synthetic siRNA and its transfection, immunoprecipitation and immunoblotting, tube formation assay in 3-dimensional type I collagen gels, mouse ischemic hindlimb model and histological analysis, and statistical analyses are described in the Material and Methods section in the online data supplement (see http://atvb.ahajournals.org).
Results
Subcellular Localization of IQGAP1 and VE-Cadherin and Their Association in Confluent Monolayers of HUVECs Before and After VEGF Stimulation
To induce angiogenesis, cell-cell contact has to be disrupted by reducing VE-cadherin from the cell-cell adhesion site. We thus examined the subcellular localization of IQGAP1 and VE-cadherin before and after VEGF stimulation in confluent monolayers of HUVECs using confocal microscopy. As shown in Figure 1 , in unstimulated ECs, IQGAP1 was mainly found at cell-cell contacts, where it colocalized with VEcadherin and was diffusely distributed within cytosol. VEGF stimulation for 1 hour reduced the staining of both VEcadherin and IQGAP1 at cell-cell contacts, consistent with the loss of cell-cell adhesions, whereas it increased the staining of IQGAP1, but not VE-cadherin, at the perinucleus area. Co-immunoprecipitation analysis revealed that IQGAP1 physically associates with VE-cadherin in the basal state. This association was slightly enhanced at 10 minutes after VEGF stimulation, and continued at least for 1 hour ( Figure  1B ; Figure IA , available online at http://atvb.ahajournals.org). This suggests that IQGAP1 remains in complex with VE-cadherin even when their staining at cell-cell contact is decreased. Western analysis of Triton-soluble and insoluble fractions as well as plasma membrane and cytosolic fractions further confirmed that the protein levels of both IQGAP1 and VE-cadherin remained unchanged during VEGF stimulation ( Figure IB and IC).
IQGAP1 Is Required for Localization of VE-Cadherin at Cell-Cell Contacts
To examine the role of IQGAP1 in localization of VEcadherin at adherence junctions in confluent monolayers of ECs, HUVECs were transfected with IQGAP1 siRNA. As shown in Figure 2 , IQGAP1 siRNA, but not scrambled siRNA, almost completely knocked down IQGAP1 protein without affecting VE-cadherin protein expression. Moreover, IQGAP1 siRNA had no effect on expression of IQGAP2 or ␤-catenin protein (data not shown), further confirming the A, Growth-arrested HUVECs were stimulated with VEGF (50 ng/mL) for 1 hour, and double-stained with anti-VE-cadherin (red) and IQGAP1 antibody (green), followed by anti-mouse Rhodamine Red X-and anti-rabbit fluoresceinisothiocyanate (FITC)-conjugated secondary antibodies, respectively. NC indicates negative control, staining with nonimmune IgG. White arrows show VEGF-induced decrease in VE-cadherin staining at cell-cell contact (red) and increase in IQGAP1 staining at the perinucleus (green). All fluorescence images were taken at 5 different fields/well, and images are representative of more than 3 independent experiments. B, HUVECs were stimulated with VEGF (50 ng/mL) and lysates were immunoprecipitated (IP) with anti-IQGAP1 antibody, followed by immunoblotting (IB) with anti-VE-cadherin or IQGAP1 antibody. Blots are representative of 3 independent experiments. specificity of IQGAP1 siRNA. IQGAP1 siRNA markedly reduced VE-cadherin staining at sites of cell-cell contact, resulting in small gaps between adjacent cells in basal and VEGF-stimulated ECs. These results suggest that IQGAP1 is required for proper localization of VE-cadherin at the adherens junctions and for VE-cadherin-mediated cell-cell adhesions in ECs.
IQGAP1
Is Required for VEGF-Induced Association of VEGFR2 With VE-Cadherin/␤-Catenin Complex VEGF stimulation promotes formation of VEGFR2/VEcadherin/␤-catenin complex, but their interaction is not direct. 4 We previously demonstrated that VEGF induces direct interaction of VEGFR2 with IQGAP1 in HUVECs. Because IQGAP1 directly binds to E-cadherin and ␤-catenin, 19 we examined whether IQGAP1 is involved in VEGF-induced formation of VEGFR2/VE-cadherin/␤-catenin complex in ECs. As shown in Figure 3 , VE-cadherin was coimmunoprecipitated with ␣-catenin and ␤-catenin in unstimulated confluent HUVECs. VEGF stimulation rapidly promoted recruitment of VEGFR2 to and dissociation of ␣-catenin from the VE-cadherin/␤-catenin complex, which was significantly inhibited by IQGAP1 siRNA. These results suggest that IQGAP1 may function as a scaffold to link VEGFR2 to the adherens junctions through binding to VEGFR2 and VE-cadherin/␤-catenin complex, thereby dissociating ␣-catenin from the adherens junctional complex, and contributing to VEGF-stimulated loss of cell-cell contacts in ECs.
IQGAP1 Is Required for ROS-Dependent Tyrosine Phosphorylation of VE-Cadherin
Because tyrosine phosphorylation of VE-cadherin is required for VEGF-induced dissociation of cell-cell contacts in ECs, 6, 9, 21 we examined whether IQGAP1 is involved in this response. As shown in Figure 4A , VEGF stimulation induced a significant increase in tyrosine phosphorylation of VEcadherin and IQGAP1 within 5 minutes. These increases were significantly inhibited by IQGAP1 siRNA. Basal phosphorylation of VE-cadherin was rather enhanced in IQGAP1 siRNA-transfected cells, presumably because of the reduction of VE-cadherin-mediated cell-cell adhesions induced by IQGAP1 depletion (Figure 2 ). Under this condition, IQGAP1 siRNA significantly inhibited VEGF-stimulated Akt phosphorylation ( Figure 4B ), which is a downstream response of formation of the VEGFR2/VE-cadherin/␤-catenin complex. 4 These results suggest that IQGAP1-mediated formation of VEGFR2/VE-cadherin/␤-catenin complex ( Figure 3 ) may be involved in VEGF-induced tyrosine phosphorylation of VEcadherin as well as Akt phosphorylation in ECs. Because we found previously that IQGAP1 is involved in VEGF-induced increase in ROS production, 12 we examined the role of ROS in phosphorylation of VE-cadherin by VEGF. IQGAP1 siRNA inhibited VEGF-stimulated ROS production ( Figure  4C ), and VEGF-stimulated tyrosine phosphorylation of VEcadherin was significantly inhibited by H 2 O 2 scavenger, polyethylene glycol (PEG)-catalase, and thiol antioxidant, NAC ( Figure 4D ). PEG only had no effects (data not shown). These results suggest that IQGAP1-mediated rapid increase Role of IQGAP1 in VEGF-induced association of VEGFR2 with VE-cadherin/␤-catenin complex. HUVECs transfected with scrambled or IQGAP1 siRNAs were stimulated with VEGF (50 ng/mL). Lysates were immunoprecipitated (IP) with anti-VE-cadherin antibody, followed by immunoblotting (IB) with anti-VEGFR2, ␣-catenin, ␤-catenin, IQGAP1, or VE-cadherin antibody. NC indicates negative control (buffer blank); PC, positive control (HUVEC total cell lysates). The graphs represent averaged data, corrected for total VE-cadherin loading, expressed as fold change of interaction from basal (set to 1). *PϽ0.05 vs untreated control in scrambled siRNA transfected cells (nϭ3).
in ROS may participate in the initial activation of VEGF signaling at the VE-cadherin-based adherens junction in ECs.
IQGAP1 Is Involved in VEGF-Stimulated Tube Formation in Type I Collagen 3-Dimensional Culture of ECs
Loss of cell-cell contacts in confluent monolayers of ECs triggers EC migration to form capillary vascular networks during angiogenesis. 2, 6 To assess the functional role of IQGAP1 in VEGF-induced angiogenesis in vitro, we examined whether IQGAP1 is involved in capillary tube formation using 3-dimensional culture of HUVECs in type I collagen gels. As shown in Figure 5 , at 24 hours after overlaying the second collagen gel containing VEGF on confluent monolayer of HUVECs seeded on top of the collagen-coated wells, capillary tube-like structures were formed in scrambled siRNA-transfected cells. Thus, this model is valuable to study the initial mechanical events of angiogenesis. In contrast, VEGF-induced tube formation was not observed in IQGAP1 siRNA-transfected cells, suggesting that IQGAP1 plays an important role in angiogenesis in vitro.
Induction of IQGAP1 Protein Expression in Mouse Ischemic Hindlimb Model of Angiogenesis
To gain further insight into the role of IQGAP1 in angiogenesis in vivo, we examined the expression of IQGAP1 in a mouse hindlimb ischemia model in which angiogenesis is dependent at least in part on VEGF, 22 VEGFR2, 23 and NAD(P)H oxidase-derived ROS. 11 Figure 6A using LDBF analysis demonstrates that hindlimb blood flow recovery was markedly decreased immediately after femoral artery ligation (day 0) and recovered to the level of that of the nonischemic limb by day 7. Western analysis also shows that IQGAP1 protein expression was significantly increased in the ischemic hindlimb tissues at 7 days after operation ( Figure 6B ) in association with the increase in VEGF expression (data not shown) compared with that in nonischemic sites. Immunocytochemical analysis of double staining for IQGAP1 and lectin showed that IQGAP1 protein and lectin-positive capillary ECs were dramatically increased and colocalized in the ischemic hindlimbs at 7 days after femoral ligation ( Figure  6C ). Similarly, VE-cadherin expression was increased in ischemic hindlimbs and partially colocalized with IQGAP1 ( Figure III ). These data indicate that IQGAP1 may be involved in the process by which new blood vessels are formed in vivo.
Discussion
Understanding the factors that regulate endothelial cell-cell junctions is important for many pathophysiological processes in which functional vascular integrity is compromised, such as development of neovasculature during angiogenesis and chronic inflammatory disorders. The present study shows that IQGAP1 colocalizes and forms a complex with VE-cadherin at the site of cell-cell contacts in unstimulated confluent HUVECs, and VEGF stimulation reduces their localization at the cell margin without affecting their complex formation. Knockdown of IQGAP1 using siRNA inhibits localization of VE-cadherin at cell-cell contacts as well as the following VEGF-stimulated events: (1) recruitment of VEGF2 to and the dissociation of ␣-catenin from the VE-cadherin/␤-catenin complex; (2) ROS-dependent tyrosine phosphorylation of VE-cadherin, which is required for loss of cell-cell contacts 8, 9 ; and (3) capillary tube formation in 3-dimensional collagen gels. We also found that IQGAP1 expression is markedly increased in the mouse hindlimb ischemia model of angiogenesis.
We previously demonstrated that IQGAP1 plays an essential role in both VEGF-induced and wound injury-induced EC migration. 12, 24 One of the initial responses to stimulate EC migration is the loosening of stable cell-cell contacts between ECs, and the molecule primarily responsible for cell-cell adhesions of ECs is the VE-cadherin. Recent studies reveal that IQGAP1 regulates E cadherin-mediated cell-cell adhesion both positively and negatively in epithelial cells. 15 However, its role in VE-cadherin-mediated cell-cell adhesion in ECs is unknown. Using confocal microscopy and co-immunoprecipitation assays, here we show that IQGAP1 colocalizes and associates with VE-cadherin at the sites of cell-cell contacts in confluent monolayers of ECs. Of note, IQGAP1, but not VE-cadherin, is also found in the cytosol in unstimulated HUVECs (Figure 1 and Figure I ). VEGF stimulation reduces IQGAP1 and VE-cadherin staining at the adherens junction, whereas it increased the staining of IQ-GAP1, but not VE-cadherin, at the perinucleus area without changing their complex formation and protein expression. Thus, it is likely that perinuclear IQGAP1 protein which is increased after VEGF stimulation may be translocated mainly from the cytosol where VE-cadherin-unbound IQGAP1 localizes in basal state. Similar results are obtained for ␤-catenin (unpublished observation). Our findings are consistent with the previous reports that both VE-cadherin and ␤-catenin are dissociated from adherens junctions as a complex without changing their protein expression in HUVEC monolayers in response to VEGF, thrombin, H 2 O 2 , and fluid shear stress. 5, [25] [26] [27] This may be because of the possibility that VE-cadherin staining using confocal microscopy in Triton X-permeabilized and fixed cultured confluent ECs reflects the disruption of cell-cell adhesion, which may reduce the accessibility to the VE-cadherin antibody presumably caused by conformational change and/or phosphorylation of VEcadherin induced by VEGF stimulation. Because Western analysis was performed in denatured condition, these factors might not be reflected. Moreover, knockdown of IQGAP1 using siRNA inhibits localization of VE-cadherin at cell-cell contacts but causes its mislocalization to the perinucleus area before and after VEGF stimulation, thereby reducing cellcell adhesions. Consistent with our result, Noritake et al 20 reported that IQGAP1 siRNA reduces the accumulation of E-cadherin and ␤-catenin at cell-cell contacts in MDCKII cells. These results suggest that IQGAP1 is required for proper localization of VE-cadherin at cell-cell contacts, and for establishment of VE-cadherin-mediated cell-cell adhesions in ECs.
It has been shown that VEGFR2 associates with VEcadherin/␤-catenin complex after VEGF stimulation to activate VE-cadherin-dependent signaling including Akt in ECs. 4 However, interaction between VEGFR2 and VEcadherin/␤-catenin is not direct. In the present study, we Figure 6 . Induction of IQGAP1 protein expression in mouse ischemic hindlimb model of angiogenesis. Hindlimb ischemia was induced by the right femoral artery ligation as described in Materials and Methods. A, Laser Doppler blood flow analysis: Arrows indicate a low perfusion signal (dark blue) detected immediately after operation (day 0) and a high perfusion signal (yellow to red) detected on day 7 in the ischemic hindlimbs. B, Western analysis of IQGAP1 and ␣-tubulin (control) protein expression in nonischemic and ischemic tissues at 7 days after operation. Graph shows averaged data, expressed as fold change of IQGAP1 expression from control (nonischemic tissue, set to 1). C, Immunofluorescence staining of nonischemic and ischemic tissues with anti-IQGAP1 antibody (red) and lectin, which stains ECs of capillaries (green) at 7 days after ischemia. White arrows in merged image show co-localization of IQGAP1 and lectin-positive capillaries. Bar graph represents averaged number of IQGAP1-positive cells and lectin-positive capillaries in nonischemic and ischemic tissues at 7 days after operation. Cells were counted in 4 randomly selected high-power fields (ϫ400, per mm 2 ). *PϽ0.05 vs nonischemic tissue (nϭ3).
show that IQGAP1 siRNA inhibits VEGF-induced recruitment of VEGFR2 to as well as dissociation of ␣-catenin from the VE-cadherin/␤-catenin complex. Because IQGAP1 directly binds to activated VEGFR2 12 as well as to E-cadherin and ␤-catenin, 19 these results suggest that IQGAP1 may function to link VEGFR2 to the adherens junctions through binding to VE-cadherin/␤-catenin complex, thereby dissociating ␣-catenin from the adherens junctional complex, which in turn results in loss of cell-cell adhesions. Given that IQGAP1 siRNA inhibits VEGF-stimulated activation of Akt, and that disrupting stable cell-cell contacts is required to stimulate EC migration, it is conceivable that IQGAP1-dependent formation of the VEGFR2/VE-cadherin/␤-catenin complex at the adherens junction is necessary for downstream activation of VEGFR2-mediated signaling linked to angiogenesis. It is important to characterize the interacting domains of IQGAP1 with its binding partners in future study.
Tyrosine phosphorylation of VE-cadherin is also critical for the loosening of cell-cell contacts in ECs. [5] [6] [7] We demonstrate here that IQGAP1 siRNA significantly inhibits VEGFstimulated tyrosine phosphorylation of VE-cadherin, whereas its response in basal state is rather enhanced presumably caused by the reduction of VE-cadherin-mediated cell-cell adhesions. Recently, VEGF-induced or Rac1-induced ROS have been shown to be involved in VE-cadherin tyrosine phosphorylation and loss of cell-cell contacts in ECs. 8, 9 We previously demonstrated that VEGF induces a rapid increase in ROS production via activation of Rac1-dependent NAD(P)H oxidase in ECs, 10 which is mediated through IQGAP1. 12 In line with these findings, the present study confirmed that IQGAP1 siRNA inhibits VEGF-stimulated increase in ROS production and that ROS inhibitors block tyrosine phosphorylation of VE-cadherin by VEGF. The mechanisms by which ROS mediate VE-cadherin phosphorylation remain unclear. Accumulating evidence suggests that ROS mediate the oxidation of critical cysteine residues in protein tyrosine phosphatases, thereby deactivating these enzymes, which results in increased tyrosine kinase activity. 28 -30 Although it is not known which protein tyrosine phosphatases may be involved, it is intriguing to note that SHP-2 has been shown to associate with VE-cadherin complex after thrombin stimulation in ECs 31 and that VEGF stimulation promotes SHP-2 binding to IQGAP1/VEGFR2/ VE-cadherin/␤-catenin complex (authors' unpublished observations). The precise underlying mechanism requires further investigation. Our present results are consistent with the possibility that VEGF-induced, IQGAP1-mediated formation of VEGFR2/VE-cadherin/␤-catenin complex is important for ROS-dependent tyrosine phosphorylation of VE-cadherin at the adherens junction, thereby facilitating loss of cell-cell contacts.
Because loss of cell-cell adhesions is an initial key event for angiogenesis, we assessed the functional role of IQGAP1 in VEGF-induced angiogenesis using in vitro and in vivo models. Using 3-dimensional cultures in type I collagen gels, an in vitro model of angiogenesis, 6 we demonstrate that VEGF-stimulated capillary-like tube formation is almost completely blocked in IQGAP1 siRNA-transfected HUVECs. We have shown that IQGAP1 is involved in VEGFstimulated EC proliferation and migration, 12 which may explain in part the mechanisms by which IQGAP1 regulates capillary tube formation in ECs. However, we cannot exclude the possibility that HUVEC data obtained in the present study may not be relevant to microvascular angiogenesis.
Study using mouse hindlimb ischemia model reveals that IQGAP1 is markedly increased in lectin-positive, newly formed capillary ECs and partially colocalizes with VEcadherin in hindlimb tissues after ischemia. Because IQGAP1 is involved in VEGF-stimulated ROS production, loss of cell-cell contacts, EC migration, and proliferation as well as capillary tube formation in cultured ECs, the functional consequence of upregulation of IQGAP1 in neovasculature is consistent with the possibility that IQGAP1 may play an important role in postnatal angiogenesis, which is dependent on VEGF, VEGFR2, and NAD(P)H oxidase-derived ROS. 11, 22, 23 The definitive role of IQGAP1 in ischemiainduced angiogenesis will require further investigation using IQGAP1 Ϫ/Ϫ mice. In summary, IQGAP1 plays an important role in establishment of VE-cadherin-based cell-cell contacts in quiescent ECs. It may also function as a scaffold protein to link VEGFR2 to the VE-cadherin/␤-catenin complex at the adherens junctions, thereby promoting ROS-dependent tyrosine phosphorylation of VE-cadherin and loss of cell-cell contacts, which may contribute to postnatal angiogenesis. These findings suggest an essential role of IQGAP1 in organization of signaling at endothelial adherens junction and provide novel insight into IQGAP1 as an attractive therapeutic target for modulating development of neovasculature during angiogenesis.
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Material and Methods
Cell Culture-Human umbilical vein ECs (HUVECs) were from VEC Technologies (Rensselaer, NY) and were grown in endothelial cell growth medium (EGM-MV, Clonetics) containing 10% fetal bovine serum. Cells between passages 3 and 6 were used. Images were taken using the confocal laser scanning imaging system Bio-Rad MRC-1024 as described previously 2, 4, 5 . In double labeling experiments, FITC and RRX images were weeks of age) were obtained from The Jackson Laboratory. Mice were subjected to unilateral hindlimb ischemia under anesthesia with intra-peritoneal administration of ketamine (87 mg/kg) and xylazine (13 mg/kg). The right superficial femoral artery was exposed and ligated proximally and distally with 5-0 silk ligatures, and excised. We measured hindlimb blood flow using a laser Doppler blood flow (LDBF) analyzer (Lisca AB)
Measurement of intracellular H
as described previously 7 . To obtain mice thigh adductor muscle in ischemic hindlimbs for immunostaining, mice at 7 days after surgery were euthanized and perfused with saline and followed by 10% formalin through the left ventricle. In some experiments, mice hindlimbs were used for immunoblotting.
Histological analysis-Hindlimb muscles were embedded in OCT compound (Sakura Finetek) and snap-frozen in liquid nitrogen. Seven-micrometer-thick sections in the ischemic and non-ischemic hindlimbs were double-stained with rabbit anti-IQGAP1 or VE-cadherin antibody and biotinylated Griffonia simplicifolia lectin (Vector Laboratories) to detect capillary ECs, followed by RRX-conjugated anti-rabbit secondary antibody and 
